1. ICH (2009) Technical Requirements for the Registration of Pharmaceuticals for Human Use, Pharmaceutical development Q8 (R2). Harmonised Tripartite Guideline, p: 1-28.
2. US FDA (2003) FDA's Pharmaceutical current Good Manufacturing Practices (cGMPs) for the 21st Century-A risk-based approach: Final report.
3. Expanding the term "Design Space" in high performance liquid chromatography (I);Monks;J Pharm Biomed Anal 56(5),2011
4. Quality by Design:Concepts for ANDAs;Lionberger;AAPS J 10(2),2008
5. Quality by design (QbD) based method development and validation of an HPLC method foe amiodarone hydrochloride and its impurities in the drug substance;Karmarkar;J Pharm Biomed Anal,2014